Peptide library
Liraglutide
Your guide to this compound.
Dose context
Individual prescription and exact product label; no catalog regimen defaults.
Dosing and preparation are indication- and presentation-specific. Use the linked prescribing information and the individual prescription; no generic dose range is assigned here.
How to read this information
Catalog ranges can describe approved labeling, clinical research or unverified reports. They are not interchangeable and do not select a personal dose.
Half-life
VICTOZA subcutaneous liraglutide: elimination half-life is approximately 13 hours; peak concentration occurs at 8–12 hours. Pediatric type 2 diabetes exposure was assessed from age 10; impaired-organ and pregnancy decisions require the complete label.
Species, route and formulation matter. Half-life does not define a safe dosing interval.
Routes and frequency in the catalog
Storage
VICTOZA: unopened 2–8°C; after first use up to 30 days at 15–30°C or 2–8°C. Do not freeze; protect from heat and sunlight.
Generic storage notes cannot establish a beyond-use date or sterility for a particular vial.
Preparation and reconstitution
Follow the exact presentation’s preparation instructions and supplied diluent. Do not transfer a mixing recipe from another brand or strength.